Kawasaki disease with giant coronary aneurysms formation in a 3-month old infant: a case report and review of the literature

被引:0
作者
Ganeva, Margarita [1 ]
Vasilev, Teodor [1 ]
Temelkova, Katya [1 ]
Hristova, Desislava [1 ]
Dimitrova, Anna [1 ]
Stefanov, Stefan [1 ]
机构
[1] Med Univ Sofia, Univ Childrens Hosp Ivan Mitev, Dept Pediat Rheumatol & Cardiol, Sofia 1606, Bulgaria
关键词
Kawasaki disease; infants; incomplete form; coronary artery aneurysms; ARTERY; AGE;
D O I
10.1080/13102818.2024.2386071
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Kawasaki disease (KD) is an acute systemic vasculitis that affects medium-sized vessels, particularly the coronary arteries. KD predominantly affects children under 5 years of age. Main symptoms include fever, bilateral conjunctivitis, polymorphous exanthema, oropharyngeal mucous membranes changes, palmar and/or plantar erythema and edema, and cervical lymphadenopathy. KD can present with a few clinical features, which might lead to a delayed diagnosis, particularly in infants. When the therapy is delayed, the diagnosis is missed or in refractory cases, there is a higher risk of coronary artery aneurysms to be formed. We report a clinical case of a 3-month-old male who presented initially with fever and cervical lymphadenopathy in whom a bacterial infection was suspected and treatment with antibiotics was started. In the course of the disease erythema of the palms and soles and generalized erythematous rash developed. The diagnosis of KD was made on the 11th day of onset of symptoms and despite the treatment with two doses of intravenous immunoglobulin, high-doses corticosteroids and infliximab, during follow-up the infant developed giant coronary artery aneurysms. A comprehensive review of the literature concerning KD in infants is included. Clinical suspicion is required to diagnose KD in the youngest patients, as they are more likely to present with few features of the disease.
引用
收藏
页数:7
相关论文
共 29 条
[1]   Kawasaki disease and the environment: an enigmatic interplay [J].
Aggarwal, Ridhima ;
Pilania, Rakesh Kumar ;
Sharma, Saniya ;
Kumar, Amit ;
Dhaliwal, Manpreet ;
Rawat, Amit ;
Singh, Surjit .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[2]   Comparison of IVIG resistance predictive models in Kawasaki disease [J].
Akca, Ummusen Kaya ;
Aydin, Elif Arslanoglu ;
Aykan, Hayrettin Hakan ;
Serin, Oguzhan ;
Sag, Erdal ;
Demir, Selcan ;
Atalay, Erdal ;
Kasap, Muserref ;
Batu, Ezgi Deniz ;
Karagoz, Tevfik ;
Bilginer, Yelda ;
Ozen, Seza .
PEDIATRIC RESEARCH, 2022, 91 (03) :621-626
[3]   Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial [J].
Burns, Jane C. ;
Roberts, Samantha C. ;
Tremoulet, Adriana H. ;
He, Feng ;
Printz, Beth F. ;
Ashouri, Negar ;
Jain, Supriya S. ;
Michalik, David E. ;
Sharma, Kavita ;
Truong, Dongngan T. ;
Wood, James B. ;
Kim, Katherine K. ;
Jain, Sonia .
LANCET CHILD & ADOLESCENT HEALTH, 2021, 5 (12) :852-861
[4]   Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease [J].
Chen, Yeshi ;
Yang, Minna ;
Zhang, Mingming ;
Wang, Hongmao ;
Zheng, Yang ;
Sun, Rui ;
Li, Xiaohui .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44 (04) :866-882
[5]   Low-dose or no aspirin administration in acute-phase Kawasaki disease: a meta-analysis and systematic review [J].
Chiang, Ming-Hsiu ;
Liu, Hsingjin Eugene ;
Wang, Jinn-Li .
ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (07) :662-667
[6]   Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort [J].
Grasa, Carlos D. ;
Fernandez-Cooke, Elisa ;
Sanchez-Manubens, Judith ;
Carazo-Gallego, Begona ;
Aracil-Santos, Javier ;
Anton, Jordi ;
Jose Lirola, Maria ;
Mercader, Beatriz ;
Villalobos, Enrique ;
Bustillo, Matilde ;
Giralt, Gemma ;
Rocandio, Beatriz ;
Escribano, Lucia M. ;
Dominguez-Rodriguez, Sara ;
Calvo, Cristina .
EUROPEAN JOURNAL OF PEDIATRICS, 2022, 181 (02) :589-598
[7]   Initial intravenous immunoglobulin therapy without aspirin for acute Kawasaki disease: a retrospective cohort study with a Bayesian inference [J].
Hayashi, Ken ;
Miyakoshi, Chisato ;
Hoshino, Shinsuke ;
Kobayashi, Naho ;
Nakajima, Ryo ;
Sagawa, Hironori ;
Hayashiya, Toshikazu ;
Suzuki, Atsushi ;
Aota, Chie ;
Nishijima, Setsuko ;
Shimizu, Yasuyo ;
Yamakawa, Masaru ;
Tsuda, Etsuko .
BMJ PAEDIATRICS OPEN, 2024, 8 (01)
[8]   Updated recommendations for action according to the S2k guidelines on Kawasaki syndrome [J].
Hospach, T. ;
Neudorf, U. ;
Lilienthal, E. ;
Jakob, A. .
MONATSSCHRIFT KINDERHEILKUNDE, 2022, 170 (12) :1122-1124
[9]   Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin [J].
Huang, Ying-Hua ;
Hsin, Yi-Chen ;
Wang, Liang-Jen ;
Feng, Wei-Ling ;
Guo, Mindy Ming-Huey ;
Chang, Ling-Sai ;
Tu, Yu-Kang ;
Kuo, Ho-Chang .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[10]  
Jakob A, 2018, PEDIATR INFECT DIS J, V37, P850, DOI [10.1097/INF.0000000000001923, 10.1097/inf.0000000000001923]